1. Repository of OAI
Ελληνικά   English  

Browsing by Author Murray, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 7 of 7
TitleAuthor(s)Issue date???itemlist.???
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancerLinardou, H.; Briasoulis, E.; Dahabreh, I. J.; Mountzios, G.; Papadimitriou, C.; Papadopoulos, S.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015-
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancerPallis, A. G.; Voutsina, A.; Kalikaki, A.; Souglakos, J.; Briasoulis, E.; Murray, S.; Koutsopoulos, A.; Tripaki, M.; Stathopoulos, E.; Mavroudis, D.; Georgoulias, V.24-Nov-2015-
Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerationsPallis, A.; Briasoulis, E.; Linardou, H.; Papadimitriou, C.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015-
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancerRoukos, D. H.; Murray, S.; Briasoulis, E.24-Nov-2015-
Predictive and Prognostic Significance of Somatic Mutations in the Tyrosine Kinase (Tk) Domain of Egfr in Nsclc Patients Treated with Single Agent Gefitinib: A Systematic Review and Meta-AnalysisMurray, S.; Evangelou, E.; Linardou, H.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J.24-Nov-2015-
Predictive Significance of Egfr Somatic Mutations and Gene Copy Number in Nsclc Patients Treated with Single Agent Tyrosine Kinase Inhibitors: A Systematic Review and Meta-AnalysisMurray, S.; Evangelou, E.; Linardou, H.; Dahabreh, I. J.; Kosmidis, P.; Bafaloukos, D.; Ioannidis, J. P. A.24-Nov-2015-
Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategiesMurray, S.; Briasoulis, E.; Linardou, H.; Bafaloukos, D.; Papadimitriou, C.24-Nov-2015-
Showing results 1 to 7 of 7